Rituximab in refractory autoimmune bullous diseases. (Record no. 16315057)

MARC details
000 -LEADER
fixed length control field 01365 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515025738.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200609s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0307-6938
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/j.1365-2230.2006.02151.x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Schmidt, E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060928
245 00 - TITLE STATEMENT
Title Rituximab in refractory autoimmune bullous diseases.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical and experimental dermatology
Date of publication, distribution, etc. Jul 2006
300 ## - PHYSICAL DESCRIPTION
Extent 503-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Murine-Derived
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Autoantibodies
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Autoimmune Diseases
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Epidermolysis Bullosa Acquisita
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunologic Factors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pemphigoid, Bullous
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pemphigus
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rituximab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Skin Diseases, Vesiculobullous
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hunzelmann, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zillikens, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bröcker, E-B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Goebeler, M
773 0# - HOST ITEM ENTRY
Title Clinical and experimental dermatology
Related parts vol. 31
-- no. 4
-- p. 503-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/j.1365-2230.2006.02151.x">https://doi.org/10.1111/j.1365-2230.2006.02151.x</a>
Public note Available from publisher's website

No items available.